Saskatoon, Canada

Paul Wood

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignee: Northwestern University. Active years: 2016-2021.

USPTO Granted Patents = 3 

% Patents Active = 33.3


 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Paul Wood: Innovator in NMDA Receptor Modulation

Introduction

Paul Wood is a notable inventor based in Saskatoon, Canada. He has made significant contributions to the field of pharmacology, particularly in the modulation of NMDA receptors. With a total of 3 patents to his name, his work focuses on developing compounds that enhance cognitive functions and alleviate neuropathic pain.

Latest Patents

One of Paul Wood's latest patents involves NMDA receptor modulators and their uses. This patent discloses compounds that exhibit enhanced potency in modulating NMDA receptor activity. These compounds are intended for the treatment of various diseases and disorders, including those affecting learning and cognitive activities. Additionally, they are particularly aimed at alleviating and reducing neuropathic pain. The patent also covers orally available formulations and other pharmaceutically acceptable delivery forms, including intravenous formulations.

Career Highlights

Paul Wood is affiliated with Northwestern University, where he continues to advance his research in pharmacology. His innovative work has garnered attention in the scientific community, contributing to the understanding of NMDA receptor functions and their implications in treating neurological disorders.

Collaborations

Some of his notable coworkers include M Amin Khan and Joseph R Moskal, who have collaborated with him on various research projects.

Conclusion

In summary, Paul Wood is a distinguished inventor whose work in NMDA receptor modulation has the potential to significantly impact the treatment of cognitive disorders and neuropathic pain. His contributions to pharmacology are noteworthy and continue to inspire further research in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…